ADDvise Group

ADDvise Group AB (publ) ("ADDvise" or the "Company") announced on 14 May 2025 that ADDvise intends to redeem the Company's outstanding senior secured bonds with ISIN SE0020180271 and ISIN NO0013180786 (the "Early Redemption").

The Early Redemption was conditional upon the entering into of the new secured facilities agreement of the equivalence of SEK 450 million with Nordea Bank Abp, filial i Sverige (the "New Facilities Agreement"), as well as on the Company receiving the proceeds from the issue of its new senior unsecured bonds of SEK 800 million (the "Bond Issue"), as communicated by the Company through a press release on 14 May 2025. As announced through the Company's press release on 26 May 2025, the Company has entered into the New Facilities Agreement and ADDvise hereby announces that the Company today has received the proceeds from the Bond Issue and that the conditions for the Early Redemption therefore has been fulfilled. The Early Redemption is therefore no longer conditional and will consequently occur on 11 June 2025.

More information regarding the Early Redemption can be found in the Company's press release published 14 May 2025.

Nordea Bank Abp acted as sole arranger and bookrunner in respect of the Bond Issue. Gernandt & Danielsson acts as legal advisor.

For further information, please contact:
Staffan Torstensson, CEO
+46 70 433 20 19
staffan.torstensson@addvisegroup.se

Johan Irwe, CFO
+46 73 731 26 11
johan.irwe@addvisegroup.se

About ADDvise Group
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 1.7 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the company's Certified Adviser. More information is available at www.addvisegroup.com.